Indoleamine 2,3-dioxygenase (IDO) supports metastatic outgrowth of the 4T1 breast cancer mouse model

被引：0
|
作者：
Smith, Courtney [1 ]
Muller, Alexander J. [1 ]
DuHadaway, James [1 ]
Prendergast, George C. [1 ]
机构：
[1] Lankenau Inst Med Res, Wynnewood, PA USA
来源：
CLINICAL & EXPERIMENTAL METASTASIS | 2011年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [1] Indoleamine 2,3-dioxygenase (IDO) inhibitors and cancer immunotherapy
    Fujiwara, Yu
    Kato, Shumei
    Nesline, Mary K.
    Conroy, Jeffrey M.
    DePietro, Paul
    Pabla, Sarabjot
    Kurzrock, Razelle
    CANCER TREATMENT REVIEWS, 2022, 110
  • [2] Development and characterization of an indoleamine 2,3-dioxygenase (IDO) deficient mouse model of preeclampsia
    Santillan, Mark
    Pelham, Christopher
    Ketsawatsomkron, Pimonrat
    Santillan, Donna
    Yang, Baoli
    Hunter, Stephen
    Sigmund, Curt
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2009, 201 (06) : S276 - S276
  • [3] Indoleamine 2,3-dioxygenase (Ido) inhibitors and their nanomedicines for cancer immunotherapy
    Guo, Yixuan
    Liu, Yu
    Wu, Wei
    Ling, Daishun
    Zhang, Qiao
    Zhao, Peng
    Hu, Xi
    BIOMATERIALS, 2021, 276
  • [4] Synthesis of indoleamine 2,3-dioxygenase (IDO) inhibitor
    Suzuki, Takafumi
    Yokoyama, Yuuaku
    Tsutumi, Katsuhiko
    Yamaguchi, Tomoyuki
    Takikawa, Osamu
    Okuno, Hiroaki
    JOURNAL OF MOLECULAR CATALYSIS B-ENZYMATIC, 2010, 62 (01) : 114 - 115
  • [5] Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies
    Selvan, Senthamil R.
    Dowling, John P.
    Kelly, William K.
    Lin, Jianqing
    CURRENT CANCER DRUG TARGETS, 2016, 16 (09) : 755 - 764
  • [6] Role of indoleamine 2,3-dioxygenase (IDO) in specific allergen immunotherapy in a mouse model of asthma
    Taher, YA
    Van Esch, ECAM
    Hofman, GA
    Bloksma, N
    Henricks, PAJ
    Van Oosterhout, AJM
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2006, 373 (01) : 98 - 98
  • [7] Inhibition Mechanisms of Indoleamine 2,3-Dioxygenase 1 (IDO1)
    Rohrig, Ute F.
    Reynaud, Aline
    Majjigapu, Somi Reddy
    Vogel, Pierre
    Pojer, Florence
    Zoete, Vincent
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (19) : 8784 - 8795
  • [8] Structure and Plasticity of Indoleamine 2,3-Dioxygenase 1 (IDO1)
    Roehrig, Ute F.
    Michielin, Olivier
    Zoete, Vincent
    JOURNAL OF MEDICINAL CHEMISTRY, 2021, 64 (24) : 17690 - 17705
  • [9] Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
    Sarah Yentz
    David Smith
    BioDrugs, 2018, 32 : 311 - 317
  • [10] Indoleamine 2,3-Dioxygenase (IDO) Inhibition as a Strategy to Augment Cancer Immunotherapy
    Yentz, Sarah
    Smith, David
    BIODRUGS, 2018, 32 (04) : 311 - 317
12345